🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors market the drug there before redirecting buyers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and chemists have cautions that the sale of what remains an unapproved medication in the UK is worrisome and could result in individuals injecting substances of uncertain source.

Some professionals said the demand for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.

Service Response and Material Removal

Based on TikTok, the platform has taken down problematic material and banned related keywords and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.

Online Trading Operations

Investigations also found communities with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, populated with images of weight loss, glowing reviews and detailed instructions for preparing or administering at home.

After moments of entering one group, a vendor posted WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.

Item Information and Costs

Within these communities, posts display black plastic parcels with postal service stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how long a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has already seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject users to potentially significant health risks”.